Author: Peter Mansell

Record gross new-business wins worth US$485 million cast a favourable light on a relatively subdued first-quarter performance by ICON, the global provider of outsourced development services based in Ireland.

The Food and Drug Administration (FDA) needs to step up the pace on modernising the regulatory framework for clinical trials in the US, says the Washington-based Association of Clinical Research Organizations (ACRO).  

Cetero Research, the early-phase contract research organisation (CRO) that recently filed for bankruptcy as a means of selling off most of its assets through a ‘stalking horse’ procedure, has reached a final resolution with the US Food and Drug Administration over the disputed bioanalytical studies behind the company’s financial decline.

US-based biopharmaceutical services company Quintiles has a new chief executive officer (CEO), Tom Pike, who has spent much of his career to date at management consulting, technology services and outsourcing specialists Accenture.

With pressure mounting on pharmaceutical companies to generate better returns from research and development expenditure, the contract research industry worldwide is forecast to show a compound annual growth rate (CAGR) of 12.8% to 2018, a new report says.